Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
25.21
0.10 (0.40%)
At close: Aug 15, 2025, 2:46 PM
Pfizer Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 29, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Dec 31, 2021 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 |
Revenue | 14.65B | 13.71B | 17.76B | 17.7B | 13.28B | 14.88B | 14.57B | 13.49B | 13.01B | 18.49B | 24.29B | 22.64B | 27.74B | 25.66B | 23.84B | 24.04B | 18.9B | 14.52B |
Cost of Revenue | 5.23B | 3.89B | 4.79B | 6.93B | 5.04B | 4.38B | 8.59B | 10.6B | 4.59B | 5.95B | 10.9B | 6.99B | 9.07B | 10.8B | 10.68B | 10.86B | 7.84B | 5B |
Gross Profit | 9.42B | 9.83B | 12.97B | 10.77B | 8.24B | 10.5B | 5.98B | 2.89B | 8.41B | 12.54B | 13.39B | 15.65B | 18.68B | 14.86B | 13.16B | 13.18B | 11.05B | 9.52B |
Operating Income | 3.58B | 4.62B | 5.72B | 4.97B | 1.88B | 4.56B | -1.26B | -3.01B | 2.35B | 6.68B | 5.35B | 9.7B | 12.95B | 10.04B | 3.28B | 7.75B | 5.99B | 4.81B |
Interest Income | 156M | 143M | 170M | 116M | 130M | 129M | 609M | 523M | 316M | 177M | 137M | 70M | 30M | 14M | 14M | 10M | 13M | n/a |
Pretax Income | 3.04B | 2.78B | -10M | 4.71B | -103M | 3.42B | -4.13B | -3.35B | 2.27B | 6.27B | 5.23B | 9B | 11.45B | 9.05B | 3.83B | 7.84B | 6.95B | 5.69B |
Net Income | 2.88B | 2.97B | 403M | 4.47B | 24M | 3.12B | -3.34B | -2.39B | 2.33B | 5.54B | 4.99B | 8.63B | 9.87B | 7.87B | 3.39B | 8.16B | 5.8B | 4.88B |
Selling & General & Admin | 3.4B | 3.02B | 4.23B | 3.24B | 3.69B | 3.46B | 4.47B | 3.21B | 3.43B | 3.36B | 4.43B | 3.25B | 2.91B | 2.52B | 3.96B | 2.75B | 2.83B | 2.71B |
Research & Development | 2.44B | 2.18B | 3.02B | 2.56B | 2.68B | 2.48B | 2.77B | 2.68B | 2.63B | 2.49B | 3.62B | 2.7B | 2.81B | 2.3B | 5.92B | 2.68B | 2.24B | 1.99B |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.84B | 5.2B | 7.24B | 5.8B | 6.36B | 5.94B | 7.24B | 5.89B | 6.06B | 5.85B | 8.04B | 5.95B | 5.73B | 4.82B | 9.88B | 5.43B | 5.07B | 4.71B |
Interest Expense | 654M | 654M | 739M | 783M | 778M | 790M | 689M | 695M | 508M | 318M | 313M | 311M | 293M | 322M | 315M | 325M | 316M | 336M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.08B | 9.09B | 12.04B | 12.73B | 11.4B | 10.32B | 15.83B | 16.5B | 10.66B | 11.8B | 18.94B | 12.94B | 14.79B | 15.62B | 20.56B | 16.29B | 12.91B | 9.71B |
Income Tax Expense | 141M | -189M | -421M | 234M | -134M | 293M | -794M | -964M | -71M | 715M | 230M | 356M | 1.57B | 1.17B | 249M | -328M | 1.12B | 808M |
Shares Outstanding (Basic) | 5.68B | 5.67B | 5.67B | 5.67B | 5.67B | 5.66B | 5.65B | 5.65B | 5.65B | 5.63B | 5.62B | 5.61B | 5.59B | 5.62B | 5.62B | 5.61B | 5.6B | 5.58B |
Shares Outstanding (Diluted) | 5.71B | 5.71B | 5.7B | 5.71B | 5.7B | 5.7B | 5.65B | 5.65B | 5.71B | 5.73B | 5.74B | 5.72B | 5.71B | 5.76B | 5.77B | 5.72B | 5.68B | 5.66B |
EPS (Basic) | 0.51 | 0.52 | 0.07 | 0.79 | 0.00 | 0.55 | -0.6 | -0.42 | 0.41 | 0.98 | 0.89 | 1.54 | 1.77 | 1.40 | 0.60 | 1.45 | 1.04 | 0.87 |
EPS (Diluted) | 0.51 | 0.52 | 0.07 | 0.78 | 0.00 | 0.55 | -0.6 | -0.42 | 0.41 | 0.97 | 0.87 | 1.51 | 1.73 | 1.37 | 0.59 | 1.43 | 1.02 | 0.86 |
EBITDA | 5.32B | 5.06B | 5.14B | 7.25B | 2.4B | 5.95B | -1.77B | -1.1B | 4.35B | 8.08B | 7.06B | 10.49B | 12.91B | 10.56B | 5.42B | 9.51B | 8.57B | 7.24B |
EBIT | 3.7B | 3.44B | 3.35B | 5.5B | 674M | 4.21B | -3.44B | -2.66B | 2.78B | 6.59B | 5.54B | 9.31B | 11.74B | 9.37B | 4.14B | 8.17B | 7.26B | 6.03B |
Depreciation & Amortization | 1.63B | 1.62B | 1.79B | 1.75B | 1.73B | 1.74B | 1.67B | 1.56B | 1.57B | 1.49B | 1.52B | 1.18B | 1.18B | 1.19B | 1.28B | 1.34B | 1.31B | 1.21B |